Stay updated on Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.

Latest updates to the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry (v3.6.6) was added and the previous one (v3.6.5) removed in the record history, indicating a platform update to the page rather than a change to the study details.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry v3.6.5 appears in the study's revision history. The previous entry v3.6.4 is removed from the updated history.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry v3.6.4 is added to the history. The previous v3.6.3 entry is removed, reflecting an update to the record's documentation.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry, v3.6.3, was added to the study record history and the previous revision v3.6.2 was removed, reflecting an update to the page's revision log.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry 'Revision: v3.6.2' was added to the Record History, replacing the previous 'Revision: v3.6.0'. This indicates a software update to the study record history page.SummaryDifference0.1%

- Check98 days agoChange DetectedOn 2026-06-08, the study status was updated to 'No longer looking for participants', indicating recruitment for this trial has closed. This change affects how users interpret the study's current availability and eligibility.SummaryDifference1%

Stay in the know with updates to Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Azacitidine in AML Post-Transplant Clinical Trial page.